Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

Chehimi J, Starr SE, Frank I, Rengaraju M, Jackson SJ, Llanes C, Kobayashi M, Perussia B, Young D, Nickbarg E, et al.

J Exp Med. 1992 Mar 1;175(3):789-96.

2.

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.

Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G.

Eur J Immunol. 1993 Aug;23(8):1826-30.

PMID:
8102101
3.
4.

Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.

Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J.

J Exp Med. 1992 Mar 1;175(3):779-88.

5.

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, et al.

J Exp Med. 1992 Nov 1;176(5):1387-98.

6.
7.
8.

Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.

Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.

J Immunol. 1985 Mar;134(3):1503-7.

PMID:
3918102
9.
10.

The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.

Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B.

Cancer Immunol Immunother. 1997 Jul;44(5):282-90.

PMID:
9247563
11.

Release of natural killer cytotoxic factor in patients with lymphoproliferative disease of granular lymphocytes.

Zambello R, Trentin L, Agostini C, Chisesi T, Vespignani M, Pizzolo G, Pandolfi F, Ensoli F, Semenzato G.

Leuk Res. 1989;13(4):315-22.

PMID:
2497276
12.

Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.

Trinchieri G, Wysocka M, D'Andrea A, Rengaraju M, Aste-Amezaga M, Kubin M, Valiante NM, Chehimi J.

Prog Growth Factor Res. 1992;4(4):355-68. Review.

PMID:
1364096
14.

Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.

Reiter Z.

Crit Rev Immunol. 1993;13(1):1-34. Review. Erratum in: Crit Rev Immunol 1993;13(2):193.

PMID:
8466640
15.

Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response.

Nomura A, Takada H, Jin CH, Tanaka T, Ohga S, Hara T.

Exp Hematol. 2001 Oct;29(10):1169-76. Review.

PMID:
11602318
16.

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G.

J Exp Med. 1989 Sep 1;170(3):827-45.

17.

Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.

Ozdemir O, Ravindranath Y, Savaşan S.

J Immunother. 2005 Jan-Feb;28(1):44-52.

PMID:
15614044
18.

[The effect of sera of breast cancer patients on NK cell activity].

Konjević G, Spuzić I.

Srp Arh Celok Lek. 1995 Sep-Oct;123(9-10):227-31. Serbian.

PMID:
17974436
19.
20.

Differences in natural killer cell quantification and receptor profile expression in HIV-1 infected Chinese children.

Fu GF, Chen X, Hao S, Zhao JL, Hu HY, Yang HT, Xu XQ, Qiu T, Li L, Xu JS, Liu XY, Huan XP, Hou YY.

Cell Immunol. 2010;265(1):37-43. doi: 10.1016/j.cellimm.2010.06.011. Epub 2010 Jul 7.

PMID:
20678758

Supplemental Content

Support Center